Gas Tamponade for Prevention of Postoperative Vitreous Hemorrhage in Diabetics

  • STATUS
    Recruiting
  • participants needed
    300
  • sponsor
    Rush Eye Associates
Updated on 5 August 2020
vitrectomy
vitreous hemorrhage
diabetes

Summary

Subjects undergo vitreous substitution with either SF6 gas or fluid during vitrectomy.

Description

Hypothesis: Subjects undergoing vitreous substitution with 30% SF6 gas during vitrectomy will have fewer postoperative vitreous hemorrhages compared to control subjects

Randomization: Subjects will be randomized according to a coin toss during PPV: heads undergo 30% SF6 gas tamponade, tails undergo vitreous substitution with fluid

Details
Condition Proliferative Diabetic Retinopathy
Age 18years - 85years
Treatment SF6, Fluid
Clinical Study IdentifierNCT04380077
SponsorRush Eye Associates
Last Modified on5 August 2020

Eligibility

Yes No Not Sure

Inclusion Criteria

b'Subject age is 18-85 years.'
b'Subject consents to study participation and is capable of 6 months of follow-up.'
b'The subject has type I or II Diabetes Mellitus with active PDR in the study eye.'
b'Best-corrected spectacle visual acuity (BCSVA) on the Snellen eye chart ranges from'
b'20/40 to hand motions in the study eye.'
b'The subject is determined to need a PPV for the primary indication of VH secondary to'
b'PDR.'

Exclusion Criteria

b'Subject has significant vitreoretinal adhesion (Grades 2 or 3) (i.e. extensive fibrous'
b'proliferation or tractional retinal detachment).'
b'Subject is known to have a significant retinal/optic nerve disease otherwise unrelated'
b'to Diabetes Mellitus, which in the opinion of the examiner is responsible for two or'
b'more lines of reduced BCSVA (macular degeneration, optic neuritis, glaucoma,'
b'amblyopia, etc.) in the study eye.'
b'Subject is known to have macular ischemia, which in the opinion of the examiner, is'
b'responsible for two or more lines of reduced BCSVA in the study eye.'
b'Subject has a significant corneal or cataract opacity, which in the opinion of the'
b'examiner, is responsible for two or more lines of reduced BCSVA (corneal scar,'
b'ectasia, etc.) in the study eye.'
b'Subject has had a previous vitrectomy (anterior or PPV) in the study eye.'
b'Subject has uncontrolled neovascular glaucoma (intraocular pressure > 30 mmHg despite'
b'medical/surgical treatment) in the study eye.'
b'Subject has uncontrolled hypertension (systolic > 200 mmHg or diastolic > 120 mmHg)'
b'despite adherence to a multiple anti-hypertensive medication regimen.'
Clear my responses

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.